New tool could predict who will suffer from steroid side effects
NCT ID NCT04664465
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to create a tool that predicts which patients with inflammatory rheumatic diseases (like rheumatoid arthritis, vasculitis, or polymyalgia rheumatica) will develop serious side effects from long-term steroid use. Researchers will collect routine medical data—such as blood tests, bone density scans, and patient history—from 300 people starting high-dose steroids. The goal is to build a simple score that helps doctors personalize treatment and reduce harm.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- glucocorticoid therapy (prednisone or equivalent)
- What this could lead to
- If successful, doctors could use a simple score to predict steroid side effects and tailor treatment plans for each patient.
- What could go wrong
- This is an observational study, not a treatment trial. The predictive score may not be accurate enough for routine use and needs further validation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANCA-ASSOCIATED VASCULITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
<CHU de Poitiers
Poitiers, France
-
CH Le Mans
Le Mans, 72000, France
-
CH des Pays de Morlaix
Morlaix, 29672, France
-
CHD Vendée
La Roche-sur-Yon, 85925, France
-
CHIC Quimper
Quimper, 29000, France
-
CHR d'Orléans
Orléans, 45067, France
-
CHRU de Brest
Brest, 29609, France
-
CHU d'Angers
Angers, 49933, France
-
CHU de Nantes - Service de Médecine interne
Nantes, 44093, France
-
CHU de Nantes - Service de Rhumatologie
Nantes, 44093, France
-
CHU de Tours
Tours, 37044, France
-
Clinique St Exupéry
Toulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Can a new drug tame vasculitis with fewer side effects?
- Engineered immune cells take aim at autoimmune kidney diseases
- Could a diabetes drug shield kidneys from autoimmune attack?
- Scientists probe kidney cell metabolism to unlock secrets of ANCA vasculitis